09.11.14
Centaur Guernsey L.P. Inc., the private equity-owned parent company of Kinetic Concepts Inc. (KCI), LifeCell Corp. and Systagenix Wound Management Ltd., is rebranding. The new name of the firm is Acelity L.P. Inc. Headquartered in San Antonio, Texas, the company’s brands operate in the wound care, biologics and regenerative medicine sectors.
“The combined knowledge of our team and global footprint allow us to continue advancing standards of patient care,” said Joe Woody, president and CEO of Centaur, now Acelity. The three divisions generate approximately $2 billion in annual revenue and market products in more than 75 countries, according to company officials.
Acelity will consist of two business segments: Advanced Wound Therapeutics and Regenerative Medicine. The wound care business includes negative pressure wound therapy, tissue matrices used for breast reconstruction and hernia repair, and collagen wound dressings. The regenerative medicine segment includes regenerative and reconstructive acellular tissue matrices for use in general and reconstructive surgical procedures to repair soft-tissue defects, as well as autologous fat grafting solutions.
“As Acelity, we want to be known worldwide for our ability to help heal wounds through solutions that address the critical unmet needs of clinicians, restore the well-being of their patients and help reduce the overall cost of patient care around the world,” said Woody.
The KCI, LifeCell and Systagenix brands will continue to exist as legal entities and will operate as Acelity subsidiaries, according to a release.
In related news, Robert Hureau, executive vice president and chief financial officer (CFO) for the former Centaur Guernsey and its subsidiaries resigned to pursue another career opportunity. His last day is Sept. 23. Following Hureau’s departure, Brian Busenlehner, vice president and corporate controller, will serve as interim CFO, working closely with Woody and the company’s senior leadership team on all financial matters. Busenlehner has served in his current role since 2007 and has been responsible for global accounting, financial consolidation and external reporting, in addition to providing leadership in support of the company’s Global Shared Service Center in Budapest, Hungary.
Efforts are underway to select a new CFO, and Acelity has retained executive search firm Crist Kolder Associates to manage the process.
“The combined knowledge of our team and global footprint allow us to continue advancing standards of patient care,” said Joe Woody, president and CEO of Centaur, now Acelity. The three divisions generate approximately $2 billion in annual revenue and market products in more than 75 countries, according to company officials.
Acelity will consist of two business segments: Advanced Wound Therapeutics and Regenerative Medicine. The wound care business includes negative pressure wound therapy, tissue matrices used for breast reconstruction and hernia repair, and collagen wound dressings. The regenerative medicine segment includes regenerative and reconstructive acellular tissue matrices for use in general and reconstructive surgical procedures to repair soft-tissue defects, as well as autologous fat grafting solutions.
“As Acelity, we want to be known worldwide for our ability to help heal wounds through solutions that address the critical unmet needs of clinicians, restore the well-being of their patients and help reduce the overall cost of patient care around the world,” said Woody.
The KCI, LifeCell and Systagenix brands will continue to exist as legal entities and will operate as Acelity subsidiaries, according to a release.
In related news, Robert Hureau, executive vice president and chief financial officer (CFO) for the former Centaur Guernsey and its subsidiaries resigned to pursue another career opportunity. His last day is Sept. 23. Following Hureau’s departure, Brian Busenlehner, vice president and corporate controller, will serve as interim CFO, working closely with Woody and the company’s senior leadership team on all financial matters. Busenlehner has served in his current role since 2007 and has been responsible for global accounting, financial consolidation and external reporting, in addition to providing leadership in support of the company’s Global Shared Service Center in Budapest, Hungary.
Efforts are underway to select a new CFO, and Acelity has retained executive search firm Crist Kolder Associates to manage the process.